Dare Bioscience Inc.

1.44-0.0500-3.36%Vol 2.31M1Y Perf 17.89%
Jul 27th, 2021 14:36 DELAYED
BID1.44 ASK1.45
Open1.48 Previous Close1.49
Pre-Market- After-Market-
 - -%  - -
Target Price
5.40 
Analyst Rating
Strong Buy 1.00
Potential %
275.00 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap71.06M 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
17.05 
Earnings Date
11th Aug 2021

Today's Price Range

1.421.49

52W Range

0.94473.85

5 Year PE Ratio Range

-0.8000-1.00

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-0.67%
1 Month
-11.83%
3 Months
-3.25%
6 Months
-35.50%
1 Year
17.89%
3 Years
26.27%
5 Years
-94.77%
10 Years
-

TickerPriceChg.Chg.%
DARE1.44-0.0500-3.36
AAPL146.48-2.5100-1.68
GOOG2 728.68-64.2100-2.30
MSFT285.24-3.8100-1.32
XOM57.66-0.8200-1.40
WFC45.100.09000.20
JNJ172.060.19000.11
FB366.70-5.7600-1.55
GE13.170.25001.93
JPM151.58-0.0700-0.05
Earnings HistoryEstimateReportedSurprise %
Q01 2021-0.23-0.1630.43
Q04 2020-0.20-0.22-10.00
Q03 2020-0.15-0.24-60.00
Q02 2020-0.14-0.27-92.86
Q01 2020-0.34-0.1847.06
Q04 2019-0.22-0.214.55
Q03 2019-0.19-0.20-5.26
Q02 2019-0.23-0.29-26.09
Earnings Per EndEstimateRevision %Trend
6/2021 QR-0.1516.67Positive
9/2021 QR-0.1710.53Positive
12/2021 FY-0.6517.72Positive
12/2022 FY-0.694.17Positive
Next Report Date11th Aug 2021
Estimated EPS Next Report-0.15
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume2.31M
Shares Outstanding49.35M
Trades Count2.73K
Dollar Volume2.16M
Avg. Volume4.92M
Avg. Weekly Volume3.49M
Avg. Monthly Volume22.18M
Avg. Quarterly Volume7.88M

Dare Bioscience Inc. (NASDAQ: DARE) stock closed at 1.49 per share at the end of the most recent trading day (a 0% change compared to the prior day closing price) with a volume of 2.14M shares and market capitalization of 71.06M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 18 people. Dare Bioscience Inc. CEO is Sabrina Martucci Johnson.

The one-year performance of Dare Bioscience Inc. stock is 17.89%, while year-to-date (YTD) performance is 11.19%. DARE stock has a five-year performance of -94.77%. Its 52-week range is between 0.9447 and 3.85, which gives DARE stock a 52-week price range ratio of 17.05%

Dare Bioscience Inc. currently has a PE ratio of -1.70, a price-to-book (PB) ratio of 22.57, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -285.07%, a ROC of -785.82% and a ROE of -912.92%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Dare Bioscience Inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.15 for the next earnings report. Dare Bioscience Inc.’s next earnings report date is 11th Aug 2021.

The consensus rating of Wall Street analysts for Dare Bioscience Inc. is Strong Buy (1), with a target price of $5.4, which is +275.00% compared to the current price. The earnings rating for Dare Bioscience Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Dare Bioscience Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Dare Bioscience Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 19.87, ATR14 : 0.16, CCI20 : -79.70, Chaikin Money Flow : -0.33, MACD : 0.00, Money Flow Index : 67.43, ROC : -25.50, RSI : 47.05, STOCH (14,3) : 6.80, STOCH RSI : 0.34, UO : 42.45, Williams %R : -93.20), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Dare Bioscience Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (100.00 %)
3 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Dare Bioscience Inc.

Dare Bioscience Inc is a clinical-stage biopharmaceutical company focused on women's reproductive health. The products of the company are related to fertility, vaginal health, and contraception. Ovaprene is a product designed by the company to provide multiple weeks of contraceptive protection without the use of hormones.

CEO: Sabrina Martucci Johnson

Telephone: +1 858 926-7655

Address: 3655 Nobel Drive, San Diego 92122, CA, US

Number of employees: 18

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

65%35%

Bearish Bullish

67%33%

News

Stocktwits